The company focused on building and unifying its many brands under a collective strategy, and engaging with partners such as the Internet portal Tencent and the FIFA World Cup. It also added three Chinese brands to its portfolio.
These developments are part of a larger strategy to energize a traditional Chinese medicine brand. Baiyunshan makes and markets Chinese and western medicine products. Guangzhou Pharmaceutical Holdings Ltd. (GPHL), predominately owned by the Guangzhou municipal government, acquired a major stake in Baiyunshan in 2013.
Net income in the first half of 2014 rose 15 percent to $109 million on revenue of $1.6 billion, an 11 percent gain. For the full year 2013, net income rose 38 percent to $159
million on 50 percent revenue jump to $2.8 billion. Baiyunshan is listed on the Shanghai and Hong Kong Stock Exchanges.